Personalizing Self-management in Diabetes - Pilot Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
BEHAVIORAL

GlucoType

GlucoType is an mobile Health intervention for facilitating self-management in T2DM built for iPhone and Android smartphones. GlucoType includes a custom-built interface for low-burden capture of diet and blood glucose (BG) levels and relies on a commercial activity tracker, FitBit, for capture of sleep and physical activity. It then applies computational phenotyping techniques to identify patterns of associations between daily activities and changes in BG levels. GlucoType uses an expert system developed by our research team to translate identified phenotypes into automatically-generated personalized behavioral goals for improving glycemic control formulated in natural language.

Trial Locations (2)

10018

Clinical Directors Network, New York

10032

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Columbia University

OTHER

NCT04757233 - Personalizing Self-management in Diabetes - Pilot Study | Biotech Hunter | Biotech Hunter